Adhering To the USD 8bn purchase of Merus, Genmab’s chief executive officer turns down more procurements in the coming years. “We do not require to,” states Jan van de Winkel.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/genmab-is-convinced-that-pipeline-will-withstand-looming-patent-gap/